 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SAN FRANCISCO and WALTHAM, Mass., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...

Apogee Therapeutics to Participate at the 2023 Stifel Virtual I&I Day

Scinai Immunotherapeutics to debut tomorrow under Nasdaq ticker symbol SCNI JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a...

BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics

Apogee Therapeutics, Inc. (NASDAQ:APGE  Free Report)  Research analysts at Wedbush raised their Q3 2023 EPS estimates for Apogee Therapeutics in a report issued on Monday, August...

Apogee Therapeutics, Inc. to Post Q3 2023 Earnings of ($0.39) Per Share, Wedbush Forecasts (NASDAQ:APGE)

Apogee Therapeutics (NASDAQ:APGE Get Free Report)s stock had its outperform rating restated by equities research analysts at William Blair in a report released on Monday, RTT News reports. They presently have a $40.00 price objective on the stock. William Blairs target price suggests a potential ...

Apogee Therapeutics (NASDAQ:APGE) Stock Rating Reaffirmed by William Blair

Apogee Therapeutics, Inc. (NASDAQ:APGE  Get Free Report)s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $23.50, but opened at $24.45. Apogee Therapeutics shares last traded at $23.55, with a volume of 10,117 shares traded. Analyst ...

Apogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $23.50

Paragon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics Paragon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics PR Newswire WALTHAM, Mass., Aug. 29, 2023 Lead program, APG777, a novel...

Paragon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics

$345 million in gross proceeds raised in upsized IPO, providing a projected operating runway into 4Q 2026 Phase 1 clinical trial initiated and first participant dosed ahead of schedule for lead product candidate, APG777, a fully optimized and half-life extended anti-IL-13 antibody for the treatment ...

Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results

Apogee Therapeutics, Inc. (NASDAQ:APGE Get Free Report)s stock price hit a new 52-week high on Tuesday . The company traded as high as $25.09 and last traded at $24.62, with a volume of 17121 shares. The stock had previously closed at $24.30. Analyst Upgrades and Downgrades Several equities analysts...

Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High at $25.09

SAN FRANCISCO and WALTHAM, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...

Apogee Therapeutics Appoints Mark C. McKenna, Healthcare Veteran and Former Chairman, President and CEO of Prometheus Biosciences, as Chairman of its Board

Apogee Therapeutics (NASDAQ:APGE  Get Free Report) quiet period will end on Wednesday, August 23rd. Apogee Therapeutics had issued 17,650,000 shares in its public offering on July 14th. The total size of the offering was $300,050,000 based on an initial share price of $17.00. During ...

Apogee Therapeutics, Inc.'s (NASDAQ:APGE) Quiet Period Set To End  on August 23rd

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in February 2022 and is headquartered in Waltham, MA.

Watchers	6
52-Wk Low	$19.96
52-Wk High	$25.54

Market Cap	$776.11M
Volume (M)	437,595.00
52-Wk High	$25.54
52-Wk Low	$19.96

APGE Apogee Therapeutics

About

Feed

News

Sentiment

Fundamentals